Kappac Pharma (Delisted) share price

BSE: 506938Pharmaceuticals & Biotechnology

Kappac Pharma Ltd. · Face value ₹10 · Listed Jan 1986

Last traded ₹112.85 on 6 Jan 2015

Delisted on 23 Nov 2023.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

Share price history

Daily closes since Feb 2007, adjusted for splits and bonuses

Daily close, ₹ per share

Results for the quarter to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
₹0.00 Cr
Net profit
−₹1.99 Cr
Earnings per share
−₹0.66

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income−2.0
  7. Finance costs0.0
  8. Profit before tax−2.0
  9. Tax0.0
  10. Net profit−2.0

Kappac Pharma results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2021. Results for the quarter to Jun 2021 were due by 14 Aug 2021, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
00.0Jun 1800.0Sep 1810.0Dec 1800.0Mar 1900.0Jun 1900.0Sep 1900.0Dec 1900.0Mar 2000.0Jun 2000.0Sep 200−0.2Dec 200−2.0Mar 21
Peak revenue ₹1.00 Cr, quarter to Dec 2018; lowest ₹0.00 Cr, quarter to Jun 2018A loss in 12 of the 12 quarters shown

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
−0.2%−0.3%−0.3%−0.2%Jun 18Dec 18Jun 19Dec 19Jun 20Dec 20Mar 21
₹ croreJun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Q1Sep 2018Dec 2018Q3Mar 2019Jun 2019Q1Sep 2019Dec 2019Q3Mar 2020Jun 2020Q1Sep 2020Dec 2020Q3Mar 2021
Revenue from operations––––––––0.000.001.000.000.000.000.000.000.000.000.000.00
––––––––0.000.001.000.040.000.000.000.000.000.000.010.00
Materials and goods bought––––––––0.000.001.000.000.000.000.000.000.000.000.000.00
Employee costs––––––––0.000.000.000.020.000.000.000.000.000.000.000.00
Other expenses––––––––0.000.000.000.020.000.000.000.000.000.000.010.00
Operating profit before depreciation––––––––0.000.000.00−0.040.000.000.000.000.000.00−0.010.00
Operating margin––––––––––−0.3%–––––––––
Depreciation and amortisation––––––––0.000.000.000.000.000.000.000.000.000.000.000.00
Other income–−0.02––––––0.000.000.000.000.000.000.000.000.000.00−0.19−1.99
Finance costs––––––––0.000.000.000.000.000.000.000.000.000.000.000.00
One-off items––––––––0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.00−0.020.00−0.040.000.000.00–0.000.000.00−0.040.000.000.000.000.000.00−0.20−1.99
Tax––––––––0.000.000.000.000.000.000.000.000.000.000.000.00
Net profit0.00−0.020.00−0.040.000.000.00–0.000.000.00−0.040.000.000.000.000.000.00−0.20−1.99
Net margin––––––––––−0.2%–––––––––
Earnings per share–––−₹0.01––––₹0.00₹0.00₹0.00−₹0.01₹0.00₹0.00₹0.00₹0.00−₹0.08₹0.00−₹0.07−₹0.66
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2018.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
−0.1Mar 12−0.1Mar 13−0.1Mar 14−0.1Mar 150.0Mar 160.0Mar 170.0Mar 1810.05.4Mar 1900.00Mar 200−2.20Mar 21
Peak revenue ₹1.00 Cr, year to Mar 2019; lowest ₹0.00 Cr, year to Mar 2020A loss in 10 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
−5.0%−5.0%−5.0%−5.0%Mar 12Mar 14Mar 16Mar 18Mar 20Mar 21

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income−2.2
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax−2.2
  10. Tax0.0
  11. Net profit−2.2

What the company owns

  • Receivables₹20 Cr
  • Plant, investments and other assets₹14 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹34 Cr
  • Other liabilities₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.

₹ croreMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue from operations–––––––1.000.000.00
–––––––1.050.020.03
Materials and goods bought–––––––1.000.000.00
Employee costs–––––––0.000.010.01
Other expenses–––––––0.050.000.01
Operating profit before depreciation–––––––−0.05−0.02−0.03
Operating margin–––––––−5.0%––
Materials, % of revenue–––––––100.0%––
Employee costs, % of revenue–––––––0.0%––
Other expenses, % of revenue–––––––5.0%––
Depreciation and amortisation–––––––0.000.000.00
Operating profit after depreciation–––––––−0.05−0.02−0.03
Other income–––––––0.000.00−2.17
Finance costs–––––––0.000.000.00
One-off items–––––––0.000.000.00
Profit before tax−0.06−0.08−0.08−0.08−0.02−0.04−0.01−0.05−0.02−2.20
Tax–––––––0.000.000.00
Net profit−0.06−0.08−0.08−0.08−0.02−0.04−0.01−0.05−0.02−2.20
Net margin–––––––−5.0%––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Earlier years, Mar 2008 to Mar 2011
₹ croreMar 2008Mar 2009Mar 2010Mar 2011
Revenue from operations−0.191.98––
Depreciation and amortisation0.07–––
Other income−0.19–––
Profit before tax−0.28–−0.01−0.05
Net profit−0.28–−0.01−0.05
Net margin149.5%–––
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021
37.936.334.1
Share capital30.330.330.3
Reserves7.66.03.8
Borrowings5.40.00.0
5.50.10.1
Liabilities due after a year0.00.00.0
Total assets43.436.434.2
38.716.714.0
4.719.620.1
Net debt5.40.00.0
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021
−2.73
−0.53
Receivables−0.54
Other working capital0.01
Capital spending0.00
Free cash flow−2.73
Cash from investing2.73
Cash from financing0.00
Dividends paid0.00
Shares bought back0.00
Shares issued0.00
Net change in cash0.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Earnings per share−₹0.01–−₹0.02−₹0.01−₹0.73
Diluted earnings per share−₹0.01–−₹0.02−₹0.01−₹0.73
Book value per share––––₹11.27

Ratios

Standalone, years to March.

RatioMar 2019Mar 2020Mar 2021
Revenue growth–−100.0%–
Return on equity−0.1%––
Return on capital employed−0.1%0.0%−0.1%
Debt to equity0.140.000.00
Receivable days0––
Inventory days0––
Payable days0––
Cash conversion cycle, days0––
Working capital days1,697––
Asset turnover0.020.000.00
Assets per rupee of net worth1.141.071.00
No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−6.2%
Measure3 years
Return on capital employed, average−0.1%
Asset turnover, average0.01
Debt to equity, average0.05

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations−2.73
Cash from investing2.73
Cash from financing0.00
Capital spending0.00
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets−6.23
A threshold marked as ours has no published figure; it is the line we read the check against.

Kappac Pharma share price by year

Each calendar year to 2015.

YearClose at year endChangeHighest closeLowest close
2015112.85−18.5%131.50112.85
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 6 Jan 2015.

Recent sessions

The 10 trading days to 6 Jan 2015, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
6 Jan 2015112.85112.85112.85112.85112.8576
5 Jan 2015118.75118.75118.75118.75118.7570,137
2 Jan 2015124.95124.95124.95124.95124.9522,190
1 Jan 2015131.50131.50131.50131.50131.50100
31 Dec 2014138.40138.40138.40138.40138.401,02,272
30 Dec 2014145.65145.65145.65145.65145.6548,027
29 Dec 2014153.30153.30153.30153.30153.3092
26 Dec 2014161.35161.35161.35161.35161.353,214
24 Dec 2014169.80169.80169.80169.80169.8011,263
23 Dec 2014211.00211.00178.70178.70184.0565,250
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
506938
ISIN
INE601D01011
Industry
Pharmaceuticals & Biotechnology
CIN
L24230MH1981PLC025002
Corporate identity number, the registrar of companies' code for it
Incorporated
1981
Registered office
3/204, Mahajbeen Arched, Plot No. H-61, New Link Road, Opp Ashiwara Police Stn., Andheri (West), Mumbai 400053, Maharashtra
Share registrar
Satellite Corporate Services Pvt Ltd
Keeps the register of shareholders and handles transfers and dividend payments